Home > Financial Ratios > ORCHID PHARMA

ORCHID PHARMA
Core EBITDA Growth

    Back to All Ratios
AD     Remove this Ad

ORCHID PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 2.2036.8263.14-3.4820.95

What is the latest Core EBITDA Growth ratio of ORCHID PHARMA ?

The latest Core EBITDA Growth ratio of ORCHID PHARMA is 2.20 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar20252.20
Mar202436.82
Mar202363.14
Mar2022-3.48
Mar202120.95

How is Core EBITDA Growth of ORCHID PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2025 2.2
-94.02
Mar2024 36.82
-41.69
Mar2023 63.14
Positive
Mar2022 -3.48
Negative
Mar2021 20.95 -

Other Financial Ratios of ORCHID PHARMA


Compare Core EBITDA Growth ratio of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹3,547.0 Cr -3.1% -14.8% -48.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,559.0 Cr 1.2% -5.3% -5.6% Stock Analytics
DIVIS LABORATORIES ₹164,827.0 Cr -3.9% -6% 11.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹136,942.0 Cr 0.9% 3.7% 20.5% Stock Analytics
CIPLA ₹106,825.0 Cr -1.2% -12.6% -6.6% Stock Analytics
DR REDDYS LABORATORIES ₹103,077.0 Cr -3.4% -5.7% 0.3% Stock Analytics


ORCHID PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

-3.1%

-14.8%

-48.4%

SENSEX

1.7%

-1.7%

10.3%


You may also like the below Video Courses